Tilray Withdraws Small Batches Of Medical Cannabis In Germany

Products “had significantly lower THC or CBD than they led them to believe”

Tilray Inc. is withdrawing a small quantity of medical cannabis in Germany, citing an issue with one of its oil.

spokeswoman for the cannabis cultivator told Marijuana Business Daily that the recall was due to “slightly lower than indicated THC potency level” on its products.

Officially, the product contains 10 milligrams per milliliter of both THC and CBD.

Tilray launched a recall of select batches voluntarily. Cannabis patients using the product are safe and not required to take any action. They may initiate a return of the product, added the spokeswoman.

Pharmacies are obliged to destroy certain products, and then wait for replacements.

They were also told to notify Paesel & Lorei, the company’s distribution partner, about the current situation.

To Read The Rest Of This Article On Benzinga, Click Here

Stay up-to-date!

Get all the news and info straight into your inbox that you need to help grow your business.

To Top